Cataracts among cancer survivors

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 6, 2005, Pages 603-608

  Stava, Charles ^a   Beck, Martha ^a   Vassilopoulou Sellin, Rena ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Cancer survivorship; Cataracts

Indexed keywords

BLEOMYCIN; BUSULFAN; CARBOPLATIN; CARMUSTINE; CHLORAMBUCIL; CISPLATIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; FOLINIC ACID; HOMOHARRINGTONINE; HYDROXYUREA; IFOSFAMIDE; IMATINIB; INTERFERON; MELPHALAN; MESNA; METHOTREXATE; MITOXANTRONE; PAMIDRONIC ACID; PROCARBAZINE; RITUXIMAB; THALIDOMIDE; THIOTEPA; VINCRISTINE; VINCRISTINE SULFATE;

ACUTE LEUKEMIA; ADULT; AGE; AGED; BONE MARROW TRANSPLANTATION; CANCER SURVIVOR; CATARACT; CHRONIC LEUKEMIA; DEMOGRAPHY; DISEASE ASSOCIATION; EDUCATION; EMPLOYMENT; ETHNOLOGY; FEMALE; GENDER; HEMATOLOGIC DISEASE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORBIDITY; MYELOMA; REVIEW; VISION;

ADRENAL CORTEX HORMONES; ADULT; AGING; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; BUSULFAN; CATARACT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISEASE SUSCEPTIBILITY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH SURVEYS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE; SOCIOECONOMIC FACTORS; SURVIVORS; WHOLE-BODY IRRADIATION;

EID: 29044439868     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000175291.51232.48     Document Type: Review

References (27)

1. American Cancer Society. Annual report to the nation on the status of cancer, 1975-2001 with a special feature regarding survival. American Cancer Society, Inc., Atlanta, Georgia. Cancer. 2004;101:3-27.
2. National Center for Health Statistics. Data from the National Health Interview Survey. 1994. Series 10, no. 188, Table 1. Available at www. cdc.gov.nchs/fastats/disable.htm.
3. Stevens MC, Mahler H, Parks S. The health status of adult survivors of cancer in childhood. Eur J Cancer. 1998;34:694-698.
4. Loescher LJ, Welch-McCaffrey D, Leigh SA, et al. Surviving adult cancers. Part 1: physiologic effects. Ann Intern Med. 1989;111:411-432.
5. Ganz PA. Late effects of cancer and its treatment. Semin Oncol Nurs. 2001;17:241-282.
6. Schultz PN, Stava C, Beck ML, et al. Health profiles in 5836 long-term cancer survivors. Int J Cancer. 2003;104:488-495.
7. Hewitt M, Breen N, Devesa S. Cancer prevalence and survivorship issues: analyses of the 1992 National Health Interview Survey. J Natl Cancer Inst. 1999;91:1480-1486.
8. Nord C, Mykletun A, Thorsen L, et al. Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer. 2004. [Epub ahead of print.]
9. Yabroff KR, Lawrence WF, Clauser S, et al. Burden of illness in cancer survivors: findings from a population-based national sample. J Natl Cancer Inst. 2004;96:1322-1330.
10. Raney RB, Asmar L, Vassilopoulou-Sellin R, et al. Late complications of therapy in 213 children with localized nonorbital soft-tissue sarcoma of the head and neck: a descriptive report from the Intergroup Rhabdomyosarcoma Studies (IRS)-111 and 111. 1RS Group of the Children's Cancer Group and the Pediatric Oncology Group. Med Pediatr Oncol. 1999;33:362-371.
11. Reddy KA, Mendenhall WM, Amdur RJ, et al. Long-term results of radiation therapy for juvenile nasopharyngeal angiofibroma. Am J Otolaryngol. 2001;22:172-175.
12. Nishino H, Miyata M, Morita M, et al. Combined therapy with conservative surgery, radiotherapy, and regional chemotherapy for maxillary sinus carcinoma. Cancer. 2000;89:1925-1932.
13. Collaborative Ocular Melanoma Study Group. Ten year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 2. Ophthalmology. 2004;111:966-976.
14. Deeg HJ. Acute and delayed toxicities of total body irradiation. Seattle Marrow Transplant Team. Int J Radiat Oncol Biol Phys. 1983;12:1933-1939.
15. Belkacemi Y, Labopin M, Vernant JP, et al. Cataracts after total body irradiation and bone marrow transplantation in patients with acute leukemia in complete remission: a study of the European Group for Blood and Marrow Transplantation. Int J Radiat Oncol Biol Phys. 1998;41:659-668.
16. Tichelli A, Gratwohl A, Egger T, et al. Cataract formation after bone marrow transplantation. Ann Int Med. 1993;119:1175-1180.
17. Leiper AD. Non-endocrine late complications of bone marrow transplantation in childhood: part 1. Br J Haematol Oncol. 2002;18:3-22.
18. Frisk P, Hagberg H, Mandahl A, et al. Cataract in children after autologous bone marrow transplantation. A common curable complication. Lakartidingen. 2002;99:1444-1447.
19. Van Kempen-Harteveld ML, Struikmans H, Kal HB, et al. Cataract after total body irradiation and bone marrow transplantation: a degree of visual impairment. Int J Radiat Oncol Biol Phys. 2002;52:1375-1380.
20. Reft C, Rash C, Dabrowski J, et al. Eye shielding for patients treated with total body irradiation. Med Dosimetry. 1996;21:73-78.
21. Hamon MD, Gale RF, Macdonald ID, et al. Incidence of cataracts after single fraction total body irradiation: the role of steroids and graft versus host disease. Bone Marrow Transplant. 1993;12:233-236.
22. Van Kempen-Harteveld ML, Belkacemi Y, Kal HB, et al. Dose-effect relationship for cataract induction after single-dose total body irradiation and bone marrow transplantation for acute leukemia. Int J Radiat Oncol Biol Phys. 2002;52:1367-1374.
23. Pakisch B, Langmann G, Langmann A, et al. Ocular sequelae of multimodal therapy of hematologic malignancies in children. Med Pediatr Oncol. 1994;23:344-349.
24. Skalka HW, Prchal JT. Effect of corticosteroids on cataract formation. Arch Ophthalmol. 1980;98:1773-1777.
25. Jobling AI, Augusteyn RC. What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom. 2002;85:61-75.
26. Carnahan MC, Goldstein DA. Ocular complications of topical, periocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478-483.
27. Landier W, Bhatia S, Eshelman DA, et al. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group long-term follow-up guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline. J Clin Oncol. 2004;22:4979-4990.